Envarsus Pa 1 mg

ENVARSUS PA 1 MG is an extended-release tablet containing tacrolimus, used for immunosuppression. This medication helps prevent organ rejection post-transplant. Learn more about ENVARSUS PA 1 MG uses and effects.

ENVARSUS PA 1 MG is primarily used to prevent organ rejection in patients who have received a liver or kidney transplant. Tacrolimus, the active ingredient, works by suppressing the immune system to reduce the risk of rejection. This medication is often prescribed as part of a broader treatment plan following transplant surgery. ENVARSUS PA 1 MG tablets are designed for extended-release, ensuring a steady level of the drug in the body.

Common effects of ENVARSUS PA 1 MG may include headaches, tremors, and gastrointestinal issues such as nausea or diarrhea. Some users might experience changes in blood pressure or blood sugar levels. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

ENVARSUS PA 1 MG should be handled with care, especially regarding dosage and administration. It is crucial to follow the prescribed regimen and avoid sudden changes without medical advice. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

ENVARSUS PA 1 MG may interact with various medications, including those that affect the liver's cytochrome P450 system. Common interactants include certain antibiotics, antifungals, and heart medications. Alcohol and other immunosuppressants should be used with caution. Always consult a healthcare provider before starting or stopping any medication while on ENVARSUS PA 1 MG.